Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

As a long term GNBT investor, I believe that it is

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 445)
Posted On: 07/29/2020 1:18:33 PM
Posted By: Assiduous
As a long term GNBT investor, I believe that it is important to remember that Joe’s GNBT vision was establisher before Covid-19, and is still valid. The Covid vaccine is a side (albeit big) opportunity to put Ii-Key to the test. BARDA funding would be a welcomed unplanned funding source, but the NGIO spin-out was not originally dependent on a Covid vaccine trial..

Caught up in the “warp speed’ mentality, Moderna will conduct their Phase 3 double blind study. No small batch trials, just 30,000 participants. They will be exposed to Covid-19, 15,000 vaccinated, best case scenario, no (presently unknown ) side effects and no virus infections, while the 15,000 placebos being exposed, getting the virus according to their natural immune responses. These volunteers will be real heroes knowing that at the very best, they only have a 50% chance of not getting Covid-19. https://www.nbcnews.com/health/health-news/ma...y-n1234979

As the saying goes; haste makes waste (human?). I think that Ii-Key will prove its value in the long haul. Patience will prove Joe’s vision in the long haul. Besides, does anyone want Generex to be added as a foot note to the following article? https://www.nbcnews.com/business/corporations...g-n1235022




(2)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us